Despite affecting millions of women in the UK, PMOS is still under-diagnosed and inconsistently managed, say experts.
People with polyendocrine metabolic ovarian syndrome (PMOS) should have their condition diagnosed sooner and be offered an annual review to monitor symptoms, treatment and long-term health risks, ...
University of Pennsylvania doctor Anuja Dokras spent the last 14 years working to rename a common medical condition that can impact fertility in women, called polycystic ovary syndrome, or PCOS.
Hormone condition PMOS affects about one in eight women, but often goes undiagnosed for years despite increasing risk of ...
Adults and children aged 10 years or older with polyendocrine metabolic ovarian syndrome (PMOS) should be offered an annual review to manage their symptoms, check medications, and assess their long ...
Dr Lucy Joslin, GP and women’s health lead at Healthcare Group, explains more about the misunderstood condition that affects ...
Polyendocrine metabolic ovarian syndrome is underdiagnosed and inconsistently managed, according to Nice ...
Read more about the National Institute for Health and Care Excellence’s new guidance on polyendocrine metabolic ovarian ...
Helena J Teede and colleagues’ global consensus to rename polycystic ovary syndrome (PCOS) as polyendocrine metabolic ovarian syndrome (PMOS) is an important advance.1 The previous term is ...
PMOS dramatically increases the risk of type 2 diabetes. The primary driver behind this increased risk is insulin resistance.
PMOS (Polyendocrine Metabolic Ovarian Syndrome), previously known as PCOS, is one of the most common hormonal conditions ...
After losing an ovary and fallopian tube due to PMOS, formerly known as PCOS, Monaleo reflects on her recovery and more. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results